TIPE1 Suppresses Growth and Metastasis of Ovarian Cancer

Table 2

Characteristics of 281 ovarian cancer patients.

Clinical characteristics	No. of cases	TIPE1 expression (median ± SD)	P value
Age (4 cases missing)
<60 years	203	112.4 ± 26.43	0.9617 ^a
≥60 years	74	111.7 ± 27.22
Tumor size (39 cases missing)
≤5 cm	55	104.3 ± 30.00	0.0833 ^a
>5 cm	187	114.2 ± 26.44
Histology
Serous	186	111.5 ± 27.00	0.5528 ^b
Mucinous	52	113.5 ± 27.96
Endometrioid	21	118.0 ± 26.63
Clear cell	19	113.5 ± 23.29
Squamous	3	123.8 ± 19.81
Metastasis
Absent	179	116.1 ± 24.08	<0.0001 ^b
Present	102	102.2 ± 28.75
Differentiation grade
Well	42	115.7 ± 24.72	0.2968 ^b
Moderate	78	110.3 ± 31.83
Poor	161	112.8 ± 24.6
Clinical stage (73 cases missing)
Stage I	17	109.1 ± 20.53	0.3252 ^b
Stage II	45	112.1 ± 30.40
Stage III	109	112.2 ± 27.48
Stage IV	37	115.1 ± 20.09

^aUnpaired t-test (two-tailed). ^bOne-way ANOVA test.